Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Lava | 2024 | Series A | $10.0M | Wilmington |
| Vitara Biomedical | 2024 | Series B | $50.0M | Philadelphia |
| Lume | 2024 | Seed | $4.2M | New York |
| RedoxBlox | 2024 | Series A | $30.0M | San Diego |
| Genie AI | 2024 | Series A | $17.8M | London |
| Verdagy | 2024 | Venture - Series Unknown | Undisclosed | Moss Landing |
| Enzymit | 2024 | Series A | $10.0M | Ness Ziona |
| Distyl AI | 2024 | Series A | $20.0M | San Francisco |
| Synex Medical | 2024 | Series A | $21.8M | Toronto |
| Inflammatix | 2024 | Series E | $57.0M | Burlingame |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 251 | Lava | Series A | $10.0M | Wilmington, United States |
| 252 | Vitara Biomedical | Series B | $50.0M | Philadelphia, United States |
| 253 | Lume | Seed | $4.2M | New York, United States |
| 254 | RedoxBlox | Series A | $30.0M | San Diego, United States |
| 255 | Genie AI | Series A | $17.8M | London, United Kingdom |
| 256 | Verdagy | Venture - Series Unknown | Undisclosed | Moss Landing, United States |
| 257 | Enzymit | Series A | $10.0M | Ness Ziona, Israel |
| 258 | Distyl AI | Series A | $20.0M | San Francisco, United States |
| 259 | Synex Medical | Series A | $21.8M | Toronto, Canada |
| 260 | Inflammatix | Series E | $57.0M | Burlingame, United States |
Lava is a bitcoin lending platform that offers a self-custodial wallet for managing bitcoin finances.
Vitara Biomedical develops a therapeutic platform to support premature infants.
Automate data mappings using AI
RedoxBlox develops thermochemical energy storage for decarbonizing industrial processes.
Automatic legal contract drafting platform for anyone.
Verdagy enables the large-scale production of green hydrogen by innovating water electrolysis technology.
Enzymit is a bioproduction platform company based on computational protein design and ‘cell-free' enzymatic manufacturing technology
Distyl AI is an artificial intelligence solution platform that services data workflows and workforce requirements.
Synex Medical develops non-invasive blood testing technology.
Inflammatix develops rapid immune system diagnostics to improve patient care and public health.
Polly is a revolutionary, end-to-end capital markets ecosystem that lenders trust to optimize performance and maximize profitability.
Openwater is a startup developing a medical technology system focused on treating diseases at the cellular level.
Fortera is a materials technology company that produces zero CO2 cement for the construction sector.
Earli develops genetic constructs for early cancer detection and targeted therapy.
Ambri is an energy storage solutions company that develops liquid metal batteries.
DevRev offers a cloud-based solution for both customer support and software development.
Neon is a software development company specializing in open-source cloud-native PostgreSQL database solutions.
On a mission to build the first Clinical Digital Twin Platform and make it accessible to everyone
Aven is a financial services company that offers a unique product known as the Aven HELOC Card.
Developer of non-invasive health technology designed to democratize access to early cancer risk assessment.
Found is a fintech company that provides business banking services for self-employed people.
Gather Health develops mobile health technology for healthcare providers, patients, and their family members
Metaplane ensures everyone trusts your business' data with automatic anomaly detection, column-level lineage, and incident prevention.
Honey Homes is a home maintenance firm that offers house maintenance and related services.
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.
Khosla Ventures has invested in 783 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Khosla Ventures's top investment sectors include Software, Biotechnology, Health Care, Artificial Intelligence (AI), Financial Services. The firm invests across 51 different industry categories.
Among tracked funding rounds, Aven received $142.0M in a Series D round. Khosla Ventures's total known invested capital is $34.0B.
Khosla Ventures's average investment size is $55.2M across its portfolio of 783 companies.
Recent Khosla Ventures portfolio additions include Lava, Vitara Biomedical, Lume, RedoxBlox, Genie AI. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors